EX-23.1 2 alrn-ex231_613.htm EX-23.1 alrn-ex231_613.htm

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-219158) of Aileron Therapeutics, Inc. of our report dated March 29, 2018 relating to the financial statements, which appears in this Form 10-K.

/s/ PricewaterhouseCoopers LLP

Boston, Massachusetts

April 2, 2018